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Abstract 
Background: Most previous studies on sleep duration and coronary heart disease (CHD) 
have been small and have inadequately controlled for cardiovascular risk factors and chronic 
diseases. Therefore, our aim was to prospectively examine the associations of sleep duration 
with CHD while accounting for these factors. 
Methods: Prospective cohort study of 392 164 adults at age 20 years or older who attended a 
health check-up program from 1994 to 2011 in Taiwan and who have information on sleep 
duration, sleep medications and potential confounders. Participants answered the question: 
‘‘How long do you sleep for?’’—there were four response categories: (a) 0–4 h; (b) 4–6 h; (c) 
6–8 h and (d) >8 h. The participants were then followed for CHD mortality from the 
Taiwanese cause-of-death register.  
Results: When compared to those who slept 6-8 hours per night, the risk of dying from CHD 
was increased by 34% (HR 1.34, 95% Confidence Interval [CI] 0.87-2.07) and 35% (HR 1.35, 
95% CI 1.11-1.65)  in those who slept less than 4 hours per night and more than 8 hours per 
night, respectively. When stratifying by sex and age, we found some evidence for a stronger 
U-shaped association in females than in males and in older adults than in younger adults (p 
for interaction = 0.01 and 0.13, respectively). 
Conclusions: Adequate sleep duration should be considered an important component of a 
healthy lifestyle. Further studies are needed to better elucidate the underlying mechanisms. 
 
Keywords: Sleep duration, coronary heart disease, cardiovascular disease, epidemiology, 
cohort study  
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Introduction 
Roughly one third of the general population regularly suffers from problems with sleep.
1
 A 
pooled analysis of the 2004–2007 waves of the National Health Interview Survey-Sample 
Adult Files (NHIS-SAF) including more than 100 000  Americans found that 28.3% of adults 
slept 6 or fewer hours, 8.5% slept 9 or more hours, and only 63.3% slept between 7 and 8 
hours.
2
 The prevalence of short sleep duration is increasing
3
 and long working hours and 
shift-work, are likely causes.
2, 4
  
A growing body of literature suggests that people with sleep problems are at increased risk for 
coronary heart disease (CHD).
5-8
 Interestingly, sleep duration was found to have a U-shaped 
association with CHD in a pooled analysis of almost 500 000 subjects.
9
 However, most 
previous studies on sleep duration and CHD have been small and have inadequately 
controlled for well-known cardiovascular risk factors and chronic diseases. Likewise, sleep 
medication can play an important role but most previous studies have not taken it into 
consideration.
10, 11
 Therefore, we prospectively examined the association of sleep duration 
with death from CHD in a large cohort of almost 400 000 Taiwanese adults taking into 
account important potential confounders, cardiovascular risk factors, sleep medications and 
chronic diseases. 
Methods 
Study population 
The study cohort consisted of 593 225 Taiwanese adults at age 20 years or older who  
participated in a large health check-up program from 1994 to 2011, run by MJ Health 
Management Institution, Taipei, Taiwan (https://www.mjclinic.com.tw). The participants 
went through a number of biochemical tests and physical examinations as previously 
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described.
12
 The analysis was based on the 392 164 (66%) participants who attended check-
ups between 1998 and 2011 and who have full information on sleep duration, sleep 
medications and potential confounding variables including sociodemographic and life style 
factors. The study participants gave their written consent for the use of their data from the 
health check-up for research. The study was approved by the National Health Research 
Institutes, Taiwan, and the MJ Health Management Institution. 
Sleep assessment 
Participants answered a question regarding sleep duration: ‘‘How long do you sleep for?’’—
there were four response categories: (a) 0–4 h; (b) 4–6 h; (c) 6–8 h and (d) >8 h. 
CHD mortality ascertainment 
From baseline, the participants were followed for CHD mortality through linkage to the 
Taiwanese cause-of-death register using the International Classification Diseases, Ninth 
Revision (ICD-9) codes 410-414 and from 2009, ICD, Tenth Revision (ICD-10) codes I20-
I25).  
Clinical information 
Participants were measured barefoot, wearing light-weight clothes. Their weight (to the 
nearest 0.1 kg) and height (to the nearest mm) were measured using an auto-anthropometer, 
Nakamura KN-5000A (Nakamura, Tokyo, Japan) and their body mass index (BMI) was 
calculated (kg/m2). After 5 minutes rest, with participants seated, blood pressure was 
measured twice at 10-minute intervals using a computerized auto-mercury 
sphygmomanometer (CH-5000, Citizen, Tokyo, Japan). We used the mean of the 2 
measurements in our analysis. Glucose, total cholesterol, high density lipoprotein cholesterol 
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(HDL-C), and triglyceride levels was measured in blood collected after overnight fasting 
using the Hitachi 7150 auto-analyzer (Hitachi Ltd., Tokyo, Japan). 
The participants reported their education (middle school or below, high school, junior college, 
college or higher), marital status (single, married, divorced or separated, widowed), smoking 
(never, former, current), alcohol consumption (no or occasional use, former drinking, regular 
drinking), physical activity (inactive, low, moderate or high). They also reported whether they 
had a history of hypertension, diabetes or heart disease.  
Statistical analyses 
The Kaplan–Meier method was used to evaluate the unadjusted risk for CHD death according 
to sleep duration. We used Cox proportional hazards models to investigate the multiadjusted 
associations of sleep duration with CHD mortality. Time at entry was the date of recruitment 
and time of exit was 31
st
 December 2011, or death if earlier.  
First, we estimated the association of sleep duration with CHD mortality controlling for age 
and sex (Model 1). In the second model we controlled for age, sex, education and marital 
status, smoking, alcohol consumption, physical activity, history of hypertension, history of 
diabetes and history of heart diseases (Model 2). In the third model, we additionally 
controlled for potential mediators including body mass index, systolic blood pressure, fasting 
glucose, total cholesterol, HDL-C, triglycerides and use of hypnotics/sedatives (Model 3). 
We also assessed the linear association of sleep duration with CHD by including sleep 
duration as a continuous variable in the models. To examine non-linear associations, we 
additionally included a quadratic term for this variable in separate models.   
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To check for effect modification by sex and age (above and below 65 years), we included 
interaction terms in the models and reported the p value for interaction. We also conducted 
analyses separately in women and men and by age group.  
 
The proportional hazards assumption was examined by plotting Schoenfeld residuals with 
time and examining their correlation. To address the possibility of reverse causation, i.e. sleep 
duration may be affected by any CHD at baseline, we excluded CHD mortality occurring in 
the first two years of follow-up and repeated the analyses. 
 
Results 
Among the 392 164 participants, there were 711 deaths from CHD during the mean follow-up 
time of 9.7 years. About 1.1% of the participants slept less than 4 hours every night, 19.6% 
slept for less than 6 hours per night, 67.6% slept between 6 and 8 hours every night and 
11.7% slept more than 8 hours every night.  
Characteristics of the participants according to usual sleep duration are presented in Table 1. 
Those who slept between 6 and 8 hours every day were least likely to present with CVD risk 
factors, i.e., they were younger, more educated, they were less likely to be regular drinkers, 
they were more physically active and they were less likely to have a history of hypertension, 
diabetes or heart disease. Those who usually slept 4 hours or less on the other hand, were 
older, less educated, more likely to be regular drinkers and had higher blood pressure than 
those sleeping more than 4 hours a night. They were also more likely to have a history of 
diabetes or heart disease.  
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Figure 1 shows Kaplan–Meier curves for CHD mortality according to sleep duration. The 
figure shows that individuals with low (0-4 hours a night) or high (>8 hours a night) sleep 
duration had increased risk of CHD death. 
There was a U-shaped association of sleep duration with CHD mortality (p for quadratic term 
ranged between 0.011 and <0.001) (Table 2). In sex and age-adjusted model (Model 1), when 
compared to those who slept 6-8 hours per night, the risk of dying from CHD was increased 
by 50% (Hazard Ratio [HR] = 1.50, 95% Confidence Interval [CI] 0.97-2.30) and 53% (HR = 
1.53, 95% CI 1.26-1.86) in those who slept less than 4 hours per night and more than 8 hours 
per night, respectively. The associations were weakened somewhat in the model adjusting for 
potential confounders (Model 2) - the risk of dying from CHD was increased by 34% (HR = 
1.34, 95% CI 0.87-2.07) and 35% (HR = 1.35, 95% CI 1.11-1.65)  in those who slept less than 
4 hours per night and more than 8 hours per night, respectively. The sleep duration-CHD 
mortality association was similar after additionally adjusting for potential mediators (Model 
3). 
There was statistical evidence for sex difference in the sleep duration-CHD mortality 
association (p for interaction = 0.014 in Model 2) (Table 3).When stratifying by sex, we found 
a stronger U-shaped association in females than in males. Compared to females sleeping 6-8 
hours per night, the risk of dying from CHD was increased by 82% (HR = 1.82, 95% CI 1.02-
3.24)  and 95% (HR = 1.95, 95% CI 1.38-2.76) in females sleeping less than 4 hours and 
more than 8 hours, respectively (Model 2). This non-linear relationship was not found in 
males.  
When stratifying by age group (above and below 65 years), we found that the U-shaped 
relationship mainly was evident in the older adults, although statistical evidence for age 
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interaction was not strong (p for interaction = 0.13 in Model 2) (Table 4), possibly due to low 
number of CHD deaths in the younger age group (n=2). In the older group, those who slept 
less than 4 hours per night had almost double the risk (HR = 1.87, 95% CI 1.18-2.97) and 
those who slept more than 8 hours per night had 50% increased risk (HR = 1.53, 95% CI 
1.20-1.95) of dying from CHD compared to those sleeping 6-8 hours per night (Model 2). In 
the younger adults, these associations were not found.  
A total of 640 CHD deaths occurred after the second year of follow-up, and by excluding 
CHD deaths occurring in the first two years the estimated associations remained essentially 
unchanged. In Model 2, the risk of dying from CHD was increased by 28% (HR = 1.28, 95% 
CI 0.80-2.03) and 31% (HR = 1.31, 95% CI 1.07-1.61) in those sleeping less than 4 hours and 
more than 8 hours, respectively.  
Discussion 
In this very large prospective study on sleep and CHD mortality, we found a U-shaped 
association of sleep duration and CHD mortality. After adjustment for potential confounders 
and cardiovascular risk factors, the strength of the association was slightly weakened but still 
present. The greatest risk was found among women sleeping less than 4 hours per night and 
more than 8 hours per night (HR = 1.82 and 1.95, respectively). The lowest risk was found in 
participants sleeping between 6 and 8 hours per night. The U-shaped relationship appeared to 
be seen mainly in women and in older adults. 
Findings in the context of previous research 
The largest prospective study on sleep duration and all-cause mortality to date followed more 
than 1.1 million individuals from the general population for mortality.
13
 They found a non-
linear association and those sleeping 7 hours per night had the lowest mortality hazard. 
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However, the researchers did not specifically look at CHD mortality. Our study is the largest 
to date on sleep duration and CHD mortality and our results are consistent with those of a 
systematic review and meta-analysis of 15 studies including 474,684 male and female 
participants, where Cappuccio et al.
9
 found that short sleep (defined as < 5–6 hours in most of 
the studies) was associated with a rate ratio (RR) of 1.48 (95% CI 1.22–1.80) and long sleep 
(defined  as >8–9 hours in most studies) was associated with a RR of 1.38 (95% CI 1.15–
1.66) of dying of or developing CHD.   
Several studies have suggested that women are more prone to sleep problems than men
14
 and 
there is a well-known sex difference in risk of cardiovascular disease and death. Thus, a sex 
difference in the association of sleep duration with CHD mortality may be plausible. A 
German study
15
 following almost 7000 subjects for 10 years found that men sleeping less than 
5 hours per night had no increased risk of having an incident myocardial infarction (HR 1.13, 
95% CI 0.66-1.92) compared to men sleeping 8 hours per night. Women sleeping less than 5 
hours per night, on the other hand, had three times the risk compared to those sleeping 8 hours 
per night (HR 2.98, 95% CI 1.48-6.03).
15
 Similar effect sizes have been reported in studies 
including only women and a study on more than 70 000 US female health professionals found 
that those sleeping less than 5 hours per night had 82% increased risk (HR 1.82, 95% CI 1.31-
2.41) of having a coronary event.
16
 Our findings support this as we found a U-shaped 
relationship only in women with those sleeping less than 4 hours having almost double the 
risk of dying from CHD compared to those sleeping 6-8 hours. However, these finding must 
be interpreted with caution. It does not necessarily suggest that short and long sleep duration 
is more dangerous in women. Instead, the sex difference might be explained by the lower 
baseline CHD risk in women. 
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Our finding that there was a stronger U-shaped association between sleep duration and CHD 
mortality in older adults (≥ 65 years) as compared to younger adults (<65) agrees with the 
results from a Korean study on 13 000 participants examining sleep duration and CVD 
mortality.
17
 They found that the U-shaped relationship was stronger in older adults (≥ 60 
years) than in younger adults (< 60 years). A study including almost 60 000 Chinese 
participants living in Singapore, found no difference in risk of CHD deaths from short or long 
sleep duration between younger and older adults.
18
 They did however, set the cut-off at 60 
years and it is possible that the increased risk occurs at an older age.   
Most previous large-scale studies have not been able to adjust for sleep medication use,
10, 11, 19
 
a potentially important confounder of the association of sleep duration with CHD mortality. 
Adjusting for sleep medication use did not considerably change the estimated association in 
our study. Neither did we find different associations of sleep duration with CHD mortality in 
sleep medication users vs. non-users.   
Possible mechanisms 
The nature of the observed prospective association between sleep duration and CHD is largely 
unknown. There are several biological plausible pathways that could potentially explain the 
prospective association. Short sleep duration is accompanied by chronic activation of stress 
responses with increased activity in the hypothalamic-pituitary-adrenal axis (HPA axis)
20
. 
This stress response is accompanied by increased heart rate, decreased heart rate variability, 
increased blood pressure and secretion of catecholamines, all strong risk factors for CHD.
21-23
 
Thus, abnormalities in the parasympathetic nervous system may represent a biologically 
plausible causal link between short sleep duration and CHD. It has also been reported that 
sleep deprivation is associated with secretion of pro-inflammatory cytokines
24
 and previous 
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studies have reported an association of short sleep duration with decreased glucose tolerance, 
insulin sensitivity, obesity and diabetes.
25-27
  
In contrast, we have no reason to suspect that increased sleep duration would cause CHD. 
There are some possible explanations however. First, residual confounding factors could be 
associated with both CHD risk and an increased need for sleep. Thus, factors we don’t have 
any information on, such as unemployment, low socioeconomic status, and undiagnosed 
health conditions may confound the association between long sleep and cardiovascular 
morbidity and mortality. In the present study, long sleepers (>8 hours a day) had a lower 
education level and higher likelihood of health conditions such as hypertension, diabetes, 
heart disease than those who slept 6-8 hours a day; we adjusted for these possible confounders 
and the association between long sleep duration and CHD deaths still remained. Although 
there could be still unadjusted residual confounding, it is also possible that long sleep duration 
itself could lead to CHD. However, we know of no plausible explanation for such a cause-
and-effect relationship. Thus, the association of long sleep duration and CHD remains 
unexplained. 
Strengths and limitations 
The main strengths of this study are its large size (almost 400 000 participants) and the record 
of sleep duration. Because of the large number of participants, we were able to separately 
assess the associations in men and women, and in younger and older adults. Furthermore, the 
detailed information collected at baseline enabled us to control for a range of possible 
confounding factors on the observed associations. 
Because some participants with short or long sleep duration at baseline could have CHD 
causing their sleep problems, it was important to address the possibility of reverse causation. 
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In a sensitivity analysis, we therefore excluded the two first years of follow-up. However, this 
did not change our estimates. 
Similar to other prospective studies, we did not assess sleep duration in an objective manner.  
A recent analysis comparing sleep durations estimated from wrist actigraphy to self-reported 
sleep in a sample of over 600 middle-aged adults indicated moderate agreement between these 
measures.
28
 Information on sleep duration was recorded at baseline only and it is likely that 
participant’s sleep patterns changed over the follow-up period; however, our checks of the 
proportional hazards assumption found no evidence that the hazard ratios associated with 
sleep duration differed over the follow-up period.  
Taiwan and some other East Asian countries such as Japan and Hong Kong have some of the 
lowest mortality rates from CHD in the world. 
29, 30
 Furthermore, our sample was relatively 
young (mean age 40.4 years), and these may have led to the relatively small number of deaths 
from CHD in our data. This may have reduced our power to detect any small effects of short 
or long sleep duration on risk of CHD death. The young age of our sample may also limit the 
generalizability of our findings to older people.  
We had no information on the prevalence of sleep apnea syndrome or depression, both 
established risk factors for cardiovascular diseases.
31, 32
 Sleep apnea patients and patients with 
depression often complain about difficulties falling asleep and being easily awoken
33, 34
 and 
the two unmeasured variables could possibly explain the unexplained increased risk found in 
long sleepers. We did however; adjust for age, sex, BMI and blood pressure, all which are 
strong correlates of sleep apnea, depression and CHD mortality. 
Observational studies inherently limit causal inference. Although we adjusted for several 
potential confounders in our multivariable analyses, we cannot exclude the possibility of 
uncontrolled confounding behind the observed associations. However, any remaining 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
15 
 
confounder potentially able to influence our results would need to be strongly associated with 
both sleep duration and CHD mortality and generally be unrelated to the factors included in 
our models.  
Finally, the sample was from a health check-up programme run by a private company and 
came from a slightly advantaged socioeconomic position compared to Taiwan’s general 
population. However, the cohort showed similar characteristics such as the prevalence of 
smoking to that shown in a national survey
35
 and the proportion of CHD deaths amongst all 
deaths was only slightly lower in the sample (5.1%) than in Taiwan’s adult population (6.2%). 
Conclusions 
Our study suggests that both short and long sleep durations may have adverse cardiovascular 
consequences. Sleeping 4 or less hours per night or 8 hours or more per night was associated 
with an increase in risk of CHD and these associations were stronger in women and in older 
adults. The associations persisted even after adjustment for established CHD risk factors. 
Given these results adequate sleep duration should be considered an important component of a 
healthy lifestyle. Finally, the explanation for the increased CHD risk in patients sleeping 8 
hours or longer is unclear. Further studies are needed to elucidate better the mechanisms 
underlying this association. 
Acknowledgements 
Linn B. Strand received a research fellowship grant from the Liaison Committee between the 
Central Norway Regional Health Authority and the Norwegian University of Science and 
Technology. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
16 
 
Figure caption 
 
Figure 1 Kaplan–Meier curves for coronary heart disease mortality according to sleep duration in the MJ health check-up programme, Taiwan 
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Tables 
 
Table 1 Characteristics of the participants by sleep duration in the MJ health check-up programme, Taiwan 
  
Total 
  Sleep duration (hour) 
  0-4 4-6 6-8 >8 
 n %  n % n % n % n % 
Number of subjects 392,164 100.0 
 
4,419 1.1 77,013 19.6 265,031 67.6 45,701 11.7 
Male 191,656 48.9  1703 38.5 37,226 48.3 132,364 49.9 20,363 44.6 
College or higher 126,702  32.3   605  13.7  22,385  29.1  90,261  34.1  13,451  29.4  
Married 258,488  65.9   3,001  67.9  49,217  63.9  176,279  66.5  29,991  65.6  
Current smoker 88,886  22.7   929  21.0  18,306  23.8  58,770  22.2  10,881  23.8  
Regular drinker 27,034  6.9   453  10.3  5,970  7.8  16,586  6.3  4,025  8.8  
Physical inactive 197,774  50.4   2,368  53.6  39,504  51.3  131,902  49.8  24,000  52.5  
History of hypertension (history 
of hypertension + use of 
antihypertensive drugs) 
32,945  8.4   799  18.1  8,249  10.7  19,553  7.4  4,344  9.5  
History of diabetes (history of 
diabetes + use of diabetes 
drugs) 
11,158  2.8   300  6.8  2,698  3.5  6,388  2.4  1,772  3.9  
History of heart diseases 
(history of heart diseases + 
history of heart surgery + use of 
heart drugs) 
14,466  3.7   411  9.3  3,744  4.9  8,364  3.2  1,947  4.3  
Use of sedatives/hypnotics 6,959  1.8   409  9.3  2,029  2.6  3,642  1.4  879  1.9  
            
 Mean sd  Mean sd Mean sd Mean sd Mean sd 
Age (years) 40.4  13.5   50.2  15.3  42.9  14.5  39.4  12.8  40.7  14.6  
BMI (kg/m2) 23.0  3.6   23.7  3.7  23.5  3.7  22.9  3.5  22.8  3.7  
Total cholesterol (mmol/L) 5.0  0.9   5.2  1.0  5.1  1.0  5.0  0.9  5.0  1.0  
HDL cholesterol (mmol/L) 1.4  0.4   1.4  0.4  1.4  0.4  1.4  0.4  1.4  0.4  
Fasting glucose (mmol/L) 5.5  1.2   5.8  1.8  5.5  1.3  5.4  1.1  5.5  1.3  
Triglycerides (mmol/L) 1.2  0.7   1.4  0.8  1.3  0.7  1.2  0.7  1.3  0.8  
Systolic blood pressure (mmHg) 119.6  18.8    125.9  21.7  121.5  19.5  119.0  18.3  119.1  19.7  
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Table 2. Hazard ratios (HR) for the association of sleep duration with CHD mortality in the MJ health check-up programme, Taiwan (N = 
392164) 
  
    Model 1  Model 2 Model 3 
cases person-years HR 
 
95% CI 
  
HR 
 
95% CI 
 
HR 
 
95% CI 
  
Sleep duration (h) 
        
0-4 22 40 966  1.50 0.97, 2.30 1.34 0.87, 2.07 1.36 0.88, 2.10 
4-6 165 705 041  1.05 0.87, 1.26 1.03 0.85, 1.23 1.03 0.85, 1.24 
6-8 382 2 600 097  1.00 
 
1.00 
 
1.00 
 
>8 142 405 585  1.53 1.26, 1.86 1.35 1.11, 1.65 1.28 1.05, 1.56 
         
p for linear trend 
  
0.040 
 
0.13 
 
0.29 
 
p for quadratic trend 
  
<0.001 
 
0.004 
 
0.011 
 
         
Model 1: Adjusted for age and sex 
Model 2: Adjusted for age, sex, education and marital status, smoking, alcohol consumption, physical activity, history of hypertension, history 
of diabetes and history of heart diseases 
Model 3: Adjusted for age, sex, education, marital status, smoking, alcohol consumption, physical activity, history of hypertension, history of 
diabetes, history of heart disease, body mass index, systolic blood pressure, fasting glucose, total cholesterol, HDL cholesterol, triglycerides 
and use of hypnotics/sedatives 
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Table 3. Hazard ratios (HR) for the association of sleep duration with CHD mortality stratified by sex, in the MJ health check-up programme, Taiwan 
(N = 392164) 
  
    Model 1 Model 2  Model 3 
cases person-years HR 95% CI  HR 95% CI HR 95% CI  
Males 
        
Sleep duration (h) 
        
0-4 9 15 843  1.14 0.59, 2.22 1.00 0.51, 1.94 1.03 0.53, 2.00 
4-6 108 339 173  1.07 0.86, 1.34 1.05 0.84, 1.31 1.06 0.85, 1.32 
6-8 279 1 292 280  
      
>8 93 176 220  1.31 1.04, 1.66 1.17 0.92 ,1.48 1.11 0.88, 1.41 
         
p for linear trend 
  
0.28 
 
0.50 
 
0.78 
 
p for quadratic trend 
  
0.064 
 
0.37 
 
0.48 
 
         
Females 
        
Sleep duration (h) 
        
0-4 13 25 122  1.94 1.09, 3.46 1.82 1.02, 3.24 1.84 1.03, 3.29 
4-6 57 365 868  1.00 0.72, 1.39 0.99 0.71, 1.37 0.99 0.72, 1.37 
6-8 103 1 307 817  1.00 
 
1.00 
 
1.00 
 
>8 49 229 365  2.30 1.64, 3.24 1.95 1.38, 2.76 1.81 1.28, 2.56 
         
p for linear trend 
  
0.022 
 
0.065 
 
0.12 
 
p for quadratic trend 
  
<0.001 
 
<0.001 
 
<0.001 
 
p for interaction by sex and sleep duration 
 
0.012 
 
0.014 
 
0.025 
 
Model 1: Adjusted for age and sex 
Model 2: Adjusted for age, sex, education and marital status, smoking, alcohol consumption, physical activity, history of hypertension, history of 
diabetes and history of heart diseases 
Model 3: Adjusted for age, sex, education, marital status, smoking, alcohol consumption, physical activity, history of hypertension, history of diabetes, 
history of heart disease, body mass index, systolic blood pressure, fasting glucose, total cholesterol, HDL cholesterol, triglycerides and use of 
hypnotics/sedatives 
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Table 4 . Hazard ratios (HR) for the associations of sleep duration with CHD mortality stratified by age group (above/below 65 years), MJ health 
check-up programme, Taiwan (N = 392164) 
  
    Model 1 Model 2  Model 3 
cases 
person-
years 
HR 
 
95% CI 
  
HR 95% CI  HR 95% CI  
Aged <65 years 
        
Sleep duration (h) 
        
0-4 2 33,409 0.41 0.10, 1.66 0.35 0.09, 1.41 0.36 0.09, 1.44 
4-6 67 639,448 1.02 0.77, 1.35 0.99 0.75, 1.32 1.00 0.76, 1.33 
6-8 182 2,465,900 1.00 
 
1.00 
 
1.00 
 
>8 43 367,432 1.32 0.94, 1.84 1.11 0.79, 1.55 1.07 0.77, 1.50 
         
p for linear trend 
  
0.13 
 
0.28 
 
0.38 
 
p for quadratic trend 
  
0.75 
 
0.56 
 
0.50 
 
         
Aged ≥ 65 years 
        
Sleep duration (h) 
        
0-4 20 7,556 2.04 1.28, 3.23 1.87 1.18, 2.97 1.88 1.18, 2.99 
4-6 98 65,593 1.07 0.84, 1.36 1.05 0.82, 1.34 1.05 0.82, 1.34 
6-8 200 134,198 1.00 
 
1.00 
 
1.00 
 
>8 99 38,153 1.70 1.33, 2.16 1.53 1.20, 1.95 1.44 1.13, 1.84 
         
p for linear trend 
  
0.12 
 
0.24 
 
0.41 
 
p for quadratic trend 
  
0.003 
 
<0.001 
 
0.002 
 
p for interaction by age and sleep duration 
 
0.18 
 
0.13 
 
0.13 
 
Model 1: Adjusted for age and sex 
        
Model 2: Adjusted for age, sex, education and marital status, smoking, alcohol consumption, physical activity, history of hypertension, history of 
diabetes and history of heart diseases 
Model 3: Adjusted for age, sex, education, marital status, smoking, alcohol consumption, physical activity, history of hypertension, history of 
diabetes, history of heart disease, body mass index, systolic blood pressure, fasting glucose, total cholesterol, HDL cholesterol, triglycerides and 
use of hypnotics/sedatives 
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